These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16785213

  • 1. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P, Gottheil E, Van Bockstaele EJ.
    J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of very low-dose naltrexone during opiate detoxification.
    Mannelli P, Gottheil E, Buonanno A, De Risio S.
    J Addict Dis; 2003; 22(2):63-70. PubMed ID: 12703669
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma naltrexone during opioid detoxification.
    McDonald T, Berkowitz R, Hoffman WE.
    J Addict Dis; 2000; 19(4):59-64. PubMed ID: 11110065
    [Abstract] [Full Text] [Related]

  • 10. [Opioid detoxication under general anesthesia].
    Zemtsovski MJ, Trosko O, Schmidt H.
    Ugeskr Laeger; 2002 Sep 02; 164(36):4165-9. PubMed ID: 12362827
    [Abstract] [Full Text] [Related]

  • 11. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D, Koutsogiannis Z, Kronborg I.
    Drug Alcohol Rev; 2003 Dec 02; 22(4):433-6. PubMed ID: 14660133
    [Abstract] [Full Text] [Related]

  • 12. [Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].
    Hensel M, Volk T, Kox WJ.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May 02; 34(5):261-8. PubMed ID: 10372215
    [Abstract] [Full Text] [Related]

  • 13. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM, Thalemann CN, Platz W, Gölz J, Partecke G.
    Biol Psychol; 2006 Mar 02; 71(3):231-5. PubMed ID: 16046046
    [Abstract] [Full Text] [Related]

  • 14. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML.
    J Pharmacol Exp Ther; 1996 Feb 02; 276(2):449-59. PubMed ID: 8632309
    [Abstract] [Full Text] [Related]

  • 15. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N, Bearn J, Gossop M, Strang J.
    Drug Alcohol Depend; 2000 May 01; 59(2):183-8. PubMed ID: 10891632
    [Abstract] [Full Text] [Related]

  • 16. Prolonged-release naloxone can cause systemic opioid withdrawal.
    Wilcock A.
    Eur J Pain; 2009 Oct 01; 13(9):1001; author reply 1002-3. PubMed ID: 19615925
    [No Abstract] [Full Text] [Related]

  • 17. [Evolution and update of detoxification techniques for opiate addicts].
    Yui K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct 01; 20(4):175-7. PubMed ID: 11215403
    [No Abstract] [Full Text] [Related]

  • 18. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM, Lowery JJ, Bhamidipati CM, Paolino RM, Blair JR, Wang D, Sadée W, Bilsky EJ.
    J Pharmacol Exp Ther; 2005 Jun 01; 313(3):1150-62. PubMed ID: 15716384
    [Abstract] [Full Text] [Related]

  • 19. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
    Fontaine E, Godfroid IO, Guillaume R.
    Encephale; 2001 Jun 01; 27(2):187-93. PubMed ID: 11407272
    [Abstract] [Full Text] [Related]

  • 20. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B, Roland CL, Goli V, Sommerville K, Webster L.
    J Opioid Manag; 2013 Jun 01; 9(2):139-50. PubMed ID: 23709323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.